aod9604 inhibits lipogenesis adipocytes In adipocytes, fatty acids from de novo (DNL) are directed Inside the Science of AOD

The 75mg dose should be administered via subcutaneous injection each morning, approximately 30 minutes before the first meal of the day

10.1038/sj.ijo.0803110 5 AlstonT

Adding AOD 9604 targeted fat breakdown may shift this ratio even further toward preferential fat loss, though controlled studies of the combination are limited

One activates the machinery, the other ensures the machinery has fuel to run

Tonight's Four Corners delves into the booming longevity industry which exploits significant gaps in health regulation, exposing consumers to risk More Information Featured: Endocrinologist Dr Katherine Samaras